| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $58.5M | +4.7% |
| SG&A Expense | $26.9M | +11.0% |
| Operating Income | -$85.4M | -6.6% |
| Pre-tax Income | -$74.8M | -8.5% |
| Income Tax | -$16.1M | — |
| Net Income | -$58.7M | +14.9% |
| EPS (Basic) | -$1.14 | +20.8% |
| EPS (Diluted) | -$1.14 | +20.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.9M | +8.4% |
| Short-term Investments | $128.6M | -22.2% |
| Current Assets | $175.7M | -15.3% |
| Total Assets | $191.3M | -24.1% |
| Current Liabilities | $14.4M | +2.4% |
| Total Liabilities | $15.2M | -42.5% |
| Stockholders' Equity | $176.1M | -22.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.3M | +7.9% |
| Capital Expenditures | $655K | -31.9% |
| Investing Cash Flow | $53.4M | +205.6% |
| Financing Cash Flow | $313K | -99.1% |
| Free Cash Flow | -$51.9M | +8.3% |